Transcriptomal analysis of failing and nonfailing human hearts

M Steenman1, Y-W Chen, M Le Cunff

  • 1Institut National de la Santé et de la Recherche Médicale U533, 44035 Nantes, France. marja.steenman@nantes.inserm.fr

Physiological Genomics
|November 14, 2002
PubMed

Insights

This study analyzed gene expression in failing and nonfailing human hearts to understand heart failure. Key differences in gene profiles were found between healthy and diseased ventricles, offering insights into cardiac dysfunction.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Genomics

Background:

  • Heart failure is a complex disease with diverse causes.
  • Understanding normal and failing cardiac function at a molecular level is crucial.

Purpose of the Study:

  • To compare gene expression profiles in failing and nonfailing human ventricles.
  • To identify molecular differences in various heart failure conditions.

Main Methods:

  • Large-scale gene expression analysis using oligonucleotide arrays (approx. 12,000 genes).
  • Analysis of left ventricle (LV) and right ventricle (RV) samples from nonfailing, dilated cardiomyopathy (DCM), and ischemic cardiomyopathy (ICM) hearts.
  • Stringent statistical analyses to identify differentially expressed genes.

Main Results:

  • Identified 1,306 genes representing the general human cardiac expression profile.
  • Found 95 differentially expressed genes between failing and nonfailing hearts, indicating dedifferentiation and apoptosis.
  • Discovered 20 genes distinguishing failing LV from failing RV.
  • No significant gene expression differences between DCM and ICM failing LVs were observed.

Conclusions:

  • Gene expression analysis reveals transcriptomal landmarks for normal and failing cardiac function.
  • Findings suggest a reversal to developmental gene expression and cardiomyocyte dedifferentiation in heart failure.
  • Transcriptomal analysis of explanted hearts reflects end-stage failure rather than specific etiologies.

Related Concept Videos